You just read:

Lannett Announces FDA Acceptance Of 505(b)(2) New Drug Application For Cocaine Hydrochloride Topical Solution, A Proprietary Anesthetic Product

News provided by

Lannett Company, Inc.

Dec 01, 2017, 05:53 EST